Mr. Speaker, I have the honour to present, in both official languages, the 21st report of the Standing Committee on Procedure and House Affairs. The committee advises that, pursuant to Standing Order 92(3)(a), the committee reports that it has concurred in the report of the Subcommittee on Private Members' Business arising that Bill C-324, An Act to amend the Controlled Drugs and Substances Act (production of or trafficking in substances) should be designated non-votable.
In the House of Commons on February 8th, 2017. See this statement in context.